|
|
Volumn 14, Issue 1, 1996, Pages 28-31
|
|
Therapeutic peptides: The devil is in the details
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AC 253;
AC 625;
ALLERVAX;
AMYLIN;
ANARITIDE;
ANTIBIOTIC AGENT;
ANTITHROMBOCYTIC AGENT;
ATRIAL NATRIURETIC FACTOR;
BRADYKININ DERIVATIVE;
BRAIN NATRIURETIC PEPTIDE;
CALCITONIN;
CSP 3001;
CSP 3012;
CSP 4003;
CVS 1123;
EPTIFIBATIDE;
GONADORELIN DERIVATIVE;
GOSERELIN;
HIRULOG;
HISTATIN;
LEUPRORELIN;
LOBRADIMIL;
MAGAININ DERIVATIVE;
N ACETYLCYSTEINYLASPARAGINYLPROLYLARGINYLGLYCYLASPARTYL(O METHYLTYROSYL)ARGINYLCYSTEINAMIDE CYCLIC 1,9 DISULFIDE;
OCCUNEX;
OMEGA CONOTOXIN MVIIA;
OXYTOCIN;
PEXIGANAN ACETATE;
PRAMLINTIDE;
PROTIRELIN;
RECOMBINANT PROTEIN;
SYNTHETIC PEPTIDE;
TECHTIDE P280;
TECHTIDE P748;
THROMBIN INHIBITOR;
THYMOSIN ALPHA1;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ALLERGY;
AMINO ACID ANALYSIS;
BIOTECHNOLOGY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
DIABETES MELLITUS;
DRUG COST;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
ENDOMETRIOSIS;
EYE DISEASE;
HORMONE SYNTHESIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG EMBOLISM;
PEPTIDE SYNTHESIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
TOPICAL DRUG ADMINISTRATION;
VIRUS INFECTION;
ANIMALS;
BIOTECHNOLOGY;
COST CONTROL;
DECISION MAKING, ORGANIZATIONAL;
HEALTH SERVICES NEEDS AND DEMAND;
HUMANS;
PEPTIDES;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 14744293121
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0196-28 Document Type: Article |
|
Times cited : (17)
|
|
References (10)
|
